Kura Oncology Inc
KURA
ISIN null / Valor 28160920
Kura Oncology Inc
UMushroom community rating:
About company
Kura Oncology is a clinical-stage biopharmaceutical company based in San Diego that develops targeted small-molecule therapies for genetically defined cancers. The company focuses on precision oncology programs that inhibit key cancer drivers and DNA damage response or epigenetic mechanisms, advancing multiple candidates through clinical trials in both solid tumors and hematologic malignancies with the goal of securing regulatory approvals and commercializing successful products. Kura funds and manages clinical development, regulatory interactions and potential partnerships to bring its pipeline to market, and its common stock is traded on the Nasdaq.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
961 M
Market cap (USD)
1,890,263
Daily traded volume (Shares)
8.65 / 8.425
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Hazem Baderon
Yiling Guo
Man Huen Chloe Lam
EQUITIES OF THE SAME SECTOR
